RAP 0.00% 20.5¢ resapp health limited

Conference Call, page-2

  1. R-7
    651 Posts.
    lightbulb Created with Sketch. 316
    @Portsmouth. Yes, great that they're following up so immediately with a conference call. I'd expect another surge of buying during and after this from 11am this morning, as Tony discusses the study and the steps forward from here to TGA/CE and FDA approvals. Great work by the RAP team, and congrats to all, esp. Prof. Abeyratne. GLTAH R-7
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.